Beauty experts unite: new guidelines for safer skin treatments in MENA

NCT ID NCT07261748

ENROLLING_BY_INVITATION Knowledge-focused Sponsor: Venus Research Center Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study brings together 15 dermatologists and aesthetic doctors from the Middle East and North Africa to create expert guidelines for using poly-L-lactic acid (PLLA) injections, a collagen-boosting treatment for skin aging. Most current guidelines are based on lighter skin types, so this project focuses on the unique needs of Fitzpatrick III-VI skin types common in the region. No patients are involved—only expert opinions collected through online surveys.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Poly-L-lactic acid (PLLA) biostimulator
What this could lead to: If successful, this could lead to region-specific guidelines that help doctors use PLLA more safely and effectively for people with darker skin types in the Middle East and North Africa.
What could go wrong: This is a small expert-opinion study with no patients or treatments involved. The final guidelines are based on consensus, not direct evidence, and may not reflect real-world outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AESTHETIC PROCEDURES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

AESTHETIC PROCEDURES COSMETIC TECHNIQUES REJUVENATION SKIN AGING

Contacts and locations

Locations

Venus Research Center

Cairo, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.